Veraxa Biotech is trading 6.9% up at $1.17, with a biotech-sector rally potentially supporting shares.
- No new company-specific announcement for October 9 was found; a search result reports no headlines for the date.
- XBI was up 2.50% during the regular session, while broad-market gains were more modest.
- The October 7 FDA-aligned R&D strategy update predates this move and is not a confirmed fresh catalyst.